On the occasion of World Cancer Day (February 4), EORTC - European Organization for Research and Treatment of Cancer and BIG - Breast International Group, entities that support LACOG - CURA, prepared a press release with the objective of increasing awareness of male breast cancer.

Breast cancer is about 100 times less common in men than in women. Due to the rarity of this disease, it is normally excluded from clinical trials and doctors generally use the treatment applied to women. In new investigations carried out, the scientists demonstrated the feasibility of carrying out a therapeutic clinical trial in a rare patient population, which represents 1 {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} of all breast cancers. The American Cancer Society estimates that around 2,550 new cases of invasive male breast cancer will be diagnosed in the United States in 2018 and that around 480 men will die from this disease. For more information, click on this link: https://www.cancer.org/conte... /DAM/CRC/PDF/Public/8584.00.pdf